Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
Descubre las razones por las cuales los hispanos tienen un riesgo elevado de sufrir diabetes tipo 2 y encuentra consejos de expertos para prevención y manejo de la...
Halloween can be a tricky holiday to navigate. Here are some ways to make trick or treating safe for people with diabetes and some other fun activities to do that don't...
Omnipod 5 users will soon be able to control their AID system through a free iPhone app available in the new year. Like the Android app, iPhone users will be able to...
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
Explore the benefits of Nevro's HFX spinal cord stimulation device for diabetic peripheral neuropathy. Recent studies show up to two years of pain relief and enhanced...
Learn about hearing loss prevention and management during National Protect Your Hearing Month. Explore the link between diabetes and hearing loss, signs of impairment,...
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
Evelyn Oberdorfer, 65, is a bodybuilder and half-marathon runner. She credits building her resilience from managing the highs and lows of type 1 diabetes since childhood.
While some affirm the health benefits of caffeine, like improving insulin sensitivity and blood sugar, research is mixed on whether it's detrimental for people with...
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
People with diabetes who are U.S. citizens or permanent residents can apply for a free lifetime America the Beautiful Pass, which offers access to over 2,000 parks,...
Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
Rising type 2 diabetes rates demand new approaches. The 2022 ADA/EASD Consensus Report emphasizes person-centered care, medications for glycemic control and weight loss...
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...

Pages